MERCK ENTERS EXCLUSIVE GLOBAL LICENSE DEAL WITH SCIBRUNCH THERAPEUTICS FOR INVESTIGATIONAL ORAL KRAS G12D (ON) INHIBITOR SPR2015

Reuters · 2d ago

Please log in to view news